Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guy Witberg

Showing results (61-70 of 117) with videos related to

Pageof 12
Sort By:
Clinical Pharmacology and Therapeutics|February 10, 2026
Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibition and Cancer Risk: Insights from a Large Propensity-Matched Cohort StudyInbar Nardi Agmon, Chen Gurevitz, Tzippy Shochat, et al.
The Israel Medical Association Journal : IMAJ|December 10, 2019
Long-term Outcomes of Contemporary Coronary Revascularization by Percutaneous Coronary Intervention or Coronary Artery Bypass Grafting in Young AdultsDror B Leviner, Guy Witberg, Amir Sharon, et al.
The American Journal of Cardiology|October 18, 2017
Transcatheter Aortic Valve Implantation Futility Risk Model Development and Validation Among Treated Patients With Aortic StenosisOren Zusman, Ran Kornowski, Guy Witberg, et al.
JACC. Cardiovascular Interventions|February 25, 2022
Clinical Outcomes of FFRangio-Guided Treatment for Coronary Artery DiseaseGuy Witberg, Tamir Bental, Amos Levi, et al.
International Journal of Cardiology|April 30, 2016
Mortality prediction following transcatheter aortic valve replacement: A quantitative comparison of risk scores derived from populations treated with either surgical or percutaneous aortic valve replacement. The Israeli TAVR Registry Risk Model Accuracy Assessment (IRRMA) studyAmir Halkin, Arie Steinvil, Guy Witberg, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|February 9, 2026
Procedural and Prognostic Implications of Guide Extension Catheter Use During Percutaneous Coronary Intervention: A Retrospective Cohort StudyEdward Itelman, Aviad Rotholz, Tamir Bental, et al.
JAMA Network Open|March 26, 2021
Change in Kidney Function and 2-Year Mortality After Transcatheter Aortic Valve ReplacementGuy Witberg, Tali Steinmetz, Uri Landes, et al.
European Journal of Preventive Cardiology|February 28, 2018
Chronic exposure to traffic-related air pollution and cancer incidence among 10,000 patients undergoing percutaneous coronary interventions: A historical prospective studyGali Cohen, Ilan Levy, Yuval, et al.
Journal of Cardiovascular Computed Tomography|October 21, 2018
Iliofemoral artery lumen volume assessment with three dimensional multi-detector computed tomography and vascular complication risk in transfemoral transcatheter aortic valve replacementYoav Hammer, Uri Landes, Oren Zusman, et al.
Cardiology|August 23, 2016
Real-World Use of Novel P2Y12 Inhibitors in Patients with Acute Myocardial Infarction: A Treatment ParadoxRoy Beigel, Zaza Iakobishvili, Nir Shlomo, et al.
Pageof 12

Showing results (61-70 of 117) with videos related to

Sort By:
Pageof 12
Clinical Pharmacology and Therapeutics|February 10, 2026
Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibition and Cancer Risk: Insights from a Large Propensity-Matched Cohort StudyInbar Nardi Agmon, Chen Gurevitz, Tzippy Shochat, et al.
The Israel Medical Association Journal : IMAJ|December 10, 2019
Long-term Outcomes of Contemporary Coronary Revascularization by Percutaneous Coronary Intervention or Coronary Artery Bypass Grafting in Young AdultsDror B Leviner, Guy Witberg, Amir Sharon, et al.
The American Journal of Cardiology|October 18, 2017
Transcatheter Aortic Valve Implantation Futility Risk Model Development and Validation Among Treated Patients With Aortic StenosisOren Zusman, Ran Kornowski, Guy Witberg, et al.
JACC. Cardiovascular Interventions|February 25, 2022
Clinical Outcomes of FFRangio-Guided Treatment for Coronary Artery DiseaseGuy Witberg, Tamir Bental, Amos Levi, et al.
International Journal of Cardiology|April 30, 2016
Mortality prediction following transcatheter aortic valve replacement: A quantitative comparison of risk scores derived from populations treated with either surgical or percutaneous aortic valve replacement. The Israeli TAVR Registry Risk Model Accuracy Assessment (IRRMA) studyAmir Halkin, Arie Steinvil, Guy Witberg, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|February 9, 2026
Procedural and Prognostic Implications of Guide Extension Catheter Use During Percutaneous Coronary Intervention: A Retrospective Cohort StudyEdward Itelman, Aviad Rotholz, Tamir Bental, et al.
JAMA Network Open|March 26, 2021
Change in Kidney Function and 2-Year Mortality After Transcatheter Aortic Valve ReplacementGuy Witberg, Tali Steinmetz, Uri Landes, et al.
European Journal of Preventive Cardiology|February 28, 2018
Chronic exposure to traffic-related air pollution and cancer incidence among 10,000 patients undergoing percutaneous coronary interventions: A historical prospective studyGali Cohen, Ilan Levy, Yuval, et al.
Journal of Cardiovascular Computed Tomography|October 21, 2018
Iliofemoral artery lumen volume assessment with three dimensional multi-detector computed tomography and vascular complication risk in transfemoral transcatheter aortic valve replacementYoav Hammer, Uri Landes, Oren Zusman, et al.
Cardiology|August 23, 2016
Real-World Use of Novel P2Y12 Inhibitors in Patients with Acute Myocardial Infarction: A Treatment ParadoxRoy Beigel, Zaza Iakobishvili, Nir Shlomo, et al.
Pageof 12